• 1
    Popper H, Schaffner F. Liver: Structure and Function. New York: McGraw-Hill Book Co.; 1957.
  • 2
    Desmet V. “Il Maestro” and the “Gnomes”. In: Berk PD, Schaffner F, Schmid R, eds. Hans Popper. A Tribute. New York: Raven Press; 1992: 4245.
  • 3
    Desmet V. Experimentele levercarcinogenese. Histochemische studie. Brussels: Arscia Uitgaven NV, Presses Académiques Européennes SC; 1963: 1366.
  • 4
    Desmet V, Vandenbroucke J. L'Hepatocarcinogénèse expérimentale. Etude histochimique. Chapter II. In: Les Tumeurs Malignes du Foie. Rapports présentés aux Journées Françaises de Gastro-entérologie. October 13–14, 1963; Paris, France; Masson & Cie Éditeurs; 1963: 4362.
  • 5
    Stewart HL, Snell KC. The histopathology of experimental tumors of the liver of the rat; a critical review of the histopathogenesis. Acta Unio Int Contra Cancrum 1957; 13: 770803.
  • 6
    Orr JW. The histology of the rat's liver during the course of carcinogenesis by butter yellow (p-dimethylaminoazobenzene). J Pathol Bacteriol 1940; 50: 393408.
  • 7
    Price JM, Harman JW, Miller EC, Miller JA. Progressive microscopic alterations in the livers of rats fed the hepatic carcinogens 3′-methyl-4-dimethylaminoazobenzene and 4′-fluoro-4-dimethylaminoazobenzene. Cancer Res 1952; 12: 192200.
  • 8
    Firminger HI. Histopathology of carcinogenesis and tumors of livers in rats. J Natl Cancer Inst 1955 ( Suppl.); 15: 14271441.
  • 9
    Wilson JW, LeDuc EH. Role of cholangioles in restoration of the liver of the mouse after dietary injury. J Pathol Bacteriol 1958; 76: 441449.
  • 10
    Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res 1956; 16: 142148.
  • 11
    Grisham JW, Hartroft WS. Morphologic identification by electron microscopy of “oval” cells in experimental hepatic degeneration. Lab Invest 1961; 10: 317332.
  • 12
    Yang L, Jung Y, Omenetti A, Witek RP, Choi S, Vandongen HM, et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008; 26: 21042113.
  • 13
    Fausto N. Liver stem cells. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The Liver: Biology and Pathobiology. 3rd ed. New York: Raven Press Ltd.; 1994: 15011518.
  • 14
    Kalengayi MM, Ronchi G, Desmet VJ. Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst 1975; 55: 579588.
  • 15
    Kalengayi MM, Desmet VJ. Sequential histological and histochemical study of the rat liver during aflatoxin B1-induced carcinogenesis. Cancer Res 1975; 35: 28452852.
  • 16
    Roskams T, De Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998; 29: 455463.
  • 17
    Vanstapel MJ, Mason DY, Desmet VJ. Immunohistochemical detection of S-100 protein in hepatocyte proliferating bile ducts [Abstract]. HEPATOLOGY 1984; 4: 784.
  • 18
    Vanstapel MJ, Butron M, Desmet VJ. Keratin immunohistochemistry in normal and pathological human liver [Abstract]. HEPATOLOGY 1984; 4: 1037.
  • 19
    van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol 1987; 412: 6372.
  • 20
    Van Eyken P, Sciot R, Callea F, Van der Steen K, Moerman P, Desmet VJ. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. HEPATOLOGY 1988; 8: 15861595.
  • 21
    Desmet VJ, Van Eyken P, Sciot R. Cytokeratins for probing cell lineage relationships in developing liver. HEPATOLOGY 1990; 12: 12491251.
  • 22
    Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol 1988; 19: 562568.
  • 23
    Van Eyken P, Sciot R, Desmet VJ. Immunocytochemistry of cytokeratins in primary human liver tumors. APMIS Suppl. 1991; 23: 7785.
  • 24
    Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993; 13: 113122.
  • 25
    De Vos R, Desmet V. Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol 1992; 140: 14411450.
  • 26
    Roskams T. Different types of liver progenitor cells and their niches. J Hepatol 2006; 45: 14.
  • 27
    Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 38183822.
  • 28
    Ishak KG, Anthony PP, Sobin LH. Histological typing of tumors of the liver. Geneva, Switzerland: World Health Organization; 1994.
  • 29
    Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006; 49: 138151.
  • 30
    Roskams T, Desmet V, Alves V, Balabaud C, Bedossa P, Bhatal P, et al. A new proposal for classification of primary liver carcinoma based on the presumed cell of origin and using K19 as a progenitor cell and prognostic marker: result of an international consensus meeting. In preparation.
  • 31
    Popper H, Paronetto F, Rubin E. Piecemeal necrosis as a reflection of immunologic hepatic injury. In: Martini GA, ed. Aktuelle Probleme der Hepatologie. 2nd Symposium of the International Association for the Study of the Liver. München und Bad Reichenhall, 1962. Stuttgart, Germany: Georg Thieme; 1962: 83.
  • 32
    Waldenström J. Liver, blood proteins and food proteins. [in German] Dtsch Z Verdau Stoffwechselkr 1952; 12: 113121.
  • 33
    Cowling DC, Mackay IR, Taft LI. Lupoid hepatitis. Lancet 1956; 271: 13231326.
  • 34
    Schmid M. Die chronische Hepatitis. Vergleichende klinische und bioptische Untersuchungen. Berlin: Springer Verlag; 1966: 1158.
  • 35
    Desmet V. Chronic hepatitis (including primary biliary cirrhosis). In: Gall EA, Mostofi FK, eds. The Liver. Baltimore: Williams & Wilkins; 1973: 286341.
  • 36
    De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968; 2: 626628.
  • 37
    Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA 1965; 191: 541546.
  • 38
    Wright R, McCollum RW, Klatskin G. Australia antigen in acute and chronic liver disease. Lancet 1969; 2: 117121.
  • 39
    Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers. Arch Pathol 1973; 96: 327330.
  • 40
    Ray MB, Desmet VJ, Bradburne AF, Desmyter J, Fevery J, De Groote J. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology 1976; 71: 462429.
  • 41
    Ray MB, Desmet VJ, Fevery J, De Groote J, Bradburne AF, Desmyter J. Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol 1976; 29: 94100.
  • 42
    Kojima T, Bloemen J, Desmet VJ. Immune electron microscopic demonstration of hepatitis B core antigen (HBcAg) in liver cell plasma membranes. Liver 1987; 7: 191200.
  • 43
    Kojima T, Callea F, Desmyter J, Desmet VJ. Immune electron microscopy of hepatitis delta-antigen in hepatocytes. Lab Invest 1986; 55: 217225.
  • 44
    Kojima T, Callea F, Desmyter J, Sakurai I, Desmet VJ. Immuno-light and electron microscopic features of chronic hepatitis D. Liver 1990; 10: 1727.
  • 45
    Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med 1970; 283: 10631071.
  • 46
    Boyer JL. Chronic hepatitis—a perspective on classification and determinants of prognosis. Gastroenterology 1976; 70: 11611171.
  • 47
    Conn HO. Chronic hepatitis: reducing an iatrogenic enigma to a workable puzzle. Gastroenterology 1976; 70: 11821184.
  • 48
    Desmet VJ. Liver lesions in hepatitis B viral infection. Yale J Biol Med 1988; 61: 6183.
  • 49
    Bardadin KA, Desmet VJ. Interdigitating and dendritic reticulum cells in chronic active hepatitis. Histopathology 1984; 8: 657667.
  • 50
    van den Oord JJ, De Vos R, Facchetti F, Delabie J, De Wolf-Peeters C, Desmet VJ. Distribution of non-lymphoid, inflammatory cells in chronic HBV infection. J Pathol 1990; 160: 223230.
  • 51
    Volpes R, van den Oord JJ, Desmet VJ. Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation. HEPATOLOGY 1991; 13: 826829.
  • 52
    Sciot R, Van den Oord JJ, De Wolf-Peeters C, Desmet VJ. In situ characterisation of the (peri)portal inflammatory infiltrate in acute hepatitis A. Liver 1986; 6: 331336.
  • 53
    De Vos R, De Wolf-Peeters C, van den Oord JJ, Desmet V. Ultrastructural immunocytochemical demonstration of HLA class I antigens in human pathological liver tissue. HEPATOLOGY 1985; 5: 10711075.
  • 54
    van den Oord JJ, de Vos R, Desmet VJ. In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. HEPATOLOGY 1986; 6: 981989.
  • 55
    Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. HEPATOLOGY 1990; 12: 5965.
  • 56
    van den Oord JJ, Fevery J, de Groote J, Desmet VJ. Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 1984; 4: 264274.
  • 57
    Van den Oord JJ, Sciot R, Desmet VJ. Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 1986; 3: 310317.
  • 58
    Volpes R, van den Oord JJ, Desmet VJ. Can hepatocytes serve as ‘activated’ immunomodulating cells in the immune response? J Hepatol 1992; 16: 228240.
  • 59
    van den Oord JJ, Volpes R, Desmet VJ. Dendritic cells and the liver. APMIS Suppl. 1991; 23: 6876.
  • 60
    Volpes R, van den Oord JJ, Desmet VJ. Lymphocyte trafficking in inflamed liver. APMIS Suppl. 1991; 23: 5367.
  • 61
    Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 2361.
  • 62
    De Wolf-Peeters C, De Vos R, Desmet V, Ray MB, Desmyter J, De Groote G, et al. Human non-A, non-B hepatitis: ultrastructural alterations in hepatocytes. Liver 1981; 1: 5055.
  • 63
    De Vos R, Vanstapel MJ, Desmyter J, De Wolf-Peeters C, De Groote G, Colaert J, et al. Are nuclear particles specific for non-A, non-B hepatitis? HEPATOLOGY 1983; 3: 532544.
  • 64
    De Vos R, De Wolf-Peeters C, Vanstapel MJ, Desmyter J, Colaert J, Mortelmans J, et al. Non-A, non-B hepatitis-like nuclear particles in nonparenchymal cells of the liver. J Infect Dis 1984; 149: 453458.
  • 65
    De Vos R, Verslype C, Depla E, Fevery J, Van Damme B, Desmet V, et al. Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies. J Hepatol 2002; 37: 370379.
  • 66
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994; 19: 15131520.
  • 67
    Hepatology Citation. HEPATOLOGY 2006; 43(2 Suppl. 1 ): S5.
  • 68
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981; 1: 431435.
  • 69
    Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696699.
  • 70
    Crawford JM. Evidence-based interpretation of liver biopsies. Lab Invest 2006; 86: 326334.
  • 71
    The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994; 20: 1520.
  • 72
    Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 13031313.
  • 73
    Sciot R, Staessen D, Van Damme B, Van Steenbergen W, Fevery J, De Groote J, et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988; 13: 593603.
  • 74
    Desmet VJ, Roskams T. Reversal of cirrhosis: evidence-based medicine? Gastroenterology 2003; 125: 629630.
  • 75
    Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40: 860867.
  • 76
    Desmet VJ. Comments on cirrhosis reversal. Dig Liver Dis 2005; 37: 909916.
  • 77
    Coons AH, Creech HJ, Jones R. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 1941; 47: 200.
  • 78
    Krstulović B, Van Damme, Desmet VJ. Comparative histochemical study of rat liver in bile-duct ligation and in alpha-napthyl isothiocyanate (ANIT) intoxication. Am J Pathol 1968; 52: 423436.
  • 79
    Ronchi G, Desmet V. Histochemical study of so-called “marker enzymes of cholestasis” during extrahepatic bile duct obstruction in the rat. Beitr Pathol 1973; 149: 213216.
  • 80
    De Vos R, De Wolf-Peeters C, Desmet V. A morphologic and histochemical study of biliary atresia in lamprey liver. Z Zellforsch Mikrosk Anat 1973; 136: 8596.
  • 81
    Busachi C, Mebis J, Broeckaert L, Desmet V. Histochemistry of gamma-glutamyl transpeptidase in human liver biopsies. Pathol Res Pract 1981; 172: 99108.
  • 82
    De Vos R, Desmet VJ. Ultrastructural aspects of cholestasis. Acta Gastroenterol Belg 1979; 42: 328333.
  • 83
    De Vos R, De Wolf-Peeters C, Desmet V. Electron microscopy of the tubule cells of rat kidney after experimental bile duct ligation. Exp Mol Pathol 1972; 16: 353361.
  • 84
    De Vos R, Desmet VJ. Morphologic changes of the junctional complex of the hepatocytes in rat liver after bile duct ligation. Br J Exp Pathol 1978; 59: 220227.
  • 85
    De Vos R, De Wolf-Peeters C, Desmet V, Bianchi L, Rohr HP. Significance of liver canalicular changes after experimental bile duct ligation. Exp Mol Pathol 1975; 23: 1234.
  • 86
    De Wolf-Peeters C, De Vos R, Desmet V. Electron microscopy and histochemistry of canalicular differentiation in fetal and neonatal rat liver. Tissue Cell 1972; 4: 379388.
  • 87
    De Wolf-Peeters C, De Vos R, Desmet V, Bianchi L, Rohr HP. Electron microscopy and morphometry of canalicular differentiation in fetal and neonatal rat liver. Exp Mol Pathol 1974; 21: 339350.
  • 88
    Desmet V. Morphologic and Histochemical Aspects of Cholestasis. In: Popper H, Schaffner F, eds. Progress in Liver Diseases, Vol IV. New York: Grune and Stratton Inc.; 1972: 97132.
  • 89
    Desmet V. Morphologic aspects of intrahepatic cholestasis. In: Gentilini P, Gorini S, Teodori U, Popper H, eds. Intrahepatic Cholestasis. New York: Raven Press; 1975: 723.
  • 90
    Desmet VJ. Current problems in diagnosis of biliary disease and cholestasis. Semin Liver Dis 1986; 6: 233245.
  • 91
    Trauner M, Boyer JL. Cholestatic syndromes. Curr Opin Gastroenterol 2002; 18: 314329.
  • 92
    Zollner G, Trauner M. Mechanisms of cholestasis. Clin Liver Dis 2008; 12: 126, vii.
  • 93
    Desmet V, Roskams T, Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995; 191: 513524.
  • 94
    Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic ‘progenitor cells’ correlates with parenchymal inflammation in chronic viral hepatitis: can ‘progenitor cells’ migrate? J Pathol 2000; 192: 373378.
  • 95
    Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express ‘bile duct-type’ cytokeratins. Histopathology 1989; 15: 125135.
  • 96
    Desmet VJ, Van Eyken P, Sciot R. Cytokeratins for probing cell lineage relationships in developing liver. HEPATOLOGY 1990; 12: 12491251.
  • 97
    Van Eyken P, Sciot R, Desmet VJ. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol 1990; 11: 4352.
  • 98
    Van Eyken P, Geerts A, De Bleser P, Lazou JM, Vrijsen R, Sciot R, et al. Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver. HEPATOLOGY 1992; 15: 909916.
  • 99
    Vanstapel MJ, Gatter KC, de Wolf-Peeters C, Mason DY, Desmet VD. New sites of human S-100 immunoreactivity detected with monoclonal antibodies. Am J Clin Pathol 1986; 85: 160168.
  • 100
    Roskams T, van den Oord JJ, De Vos R, Desmet VJ. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 1990; 137: 10191025.
  • 101
    Roskams T, Campos RV, Drucker DJ, Desmet VJ. Reactive human bile ductules express parathyroid hormone-related peptide. Histopathology 1993; 23: 1119.
  • 102
    Roskams T, De Vos R, van den Oord JJ, Desmet V. Cells with neuroendocrine features in regenerating human liver. APMIS Suppl. 1991; 23: 3239.
  • 103
    Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 2003; 200: 553560.
  • 104
    Vander Borght S, Libbrecht L, Katoonizadeh A, van Pelt J, Cassiman D, Nevens F, et al. Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences. J Histochem Cytochem 2006; 54: 10511059.
  • 105
    Roskams T, Cassiman D, De Vos R, Libbrecht L. Neuroregulation of the neuroendocrine compartment of the liver. Anat Rec A Discov Mol Cell Evol Biol 2004; 280: 910923.
  • 106
    Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004; 39: 17391745.
  • 107
    Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J Mt Sinai Hosp N Y 1957; 24: 551556.
  • 108
    Zajicek G, Oren R, Weinreb M Jr. The streaming liver. Liver 1985; 5: 293300.
  • 109
    Bralet MP, Branchereau S, Brechot C, Ferry N. Cell lineage study in the liver using retroviral mediated gene transfer. Evidence against the streaming of hepatocytes in normal liver. Am J Pathol 1994; 144: 896905.
  • 110
    MacSween RNM, Desmet VJ, Roskams T, Scothorne RJ. Developmental anatomy and normal structure. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver. 4th ed. London: Churchill Livingstone; 2002: 910.
  • 111
    Stowens D. Congenital biliary atresia. Ann N Y Acad Sci 1963; 111: 337357.
  • 112
    Jørgensen MJ. The ductal plate malformation. Acta Pathol Microbiol Scand Suppl. 1977; 257: 187.
  • 113
    Desmet VJ, Callea F. Cholestatic syndromes of infancy and childhood. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease. Vol. 2. ed 2. Philadelphia: WB Saunders Co.; 1990: 13551395.
  • 114
    Raweily EA, Gibson AA, Burt AD. Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology 1990; 17: 521527.
  • 115
    Awasthi A, Das A, Srinivasan R, Joshi K. Morphological and immunohistochemical analysis of ductal plate malformation: correlation with fetal liver. Histopathology 2004; 45: 260267.
  • 116
    Low Y, Vijayan V, Tan CE. The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: an immunohistochemical study. J Pediatr 2001; 139: 320322.
  • 117
    Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. HEPATOLOGY 1992; 16: 10691083.
  • 118
    Desmet VJ. Ludwig symposium on biliary disorders—part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998; 73: 8089.
  • 119
    Marchal GJ, Desmet VJ, Proesmans WC, Moerman PL, Van Roost WW, Van Holsbeeck MT, et al. Caroli disease: high-frequency US and pathologic findings. Radiology 1986; 158: 507511.
  • 120
    Choi BI, Yeon KM, Kim SH, Han MC. Caroli disease: central dot sign in CT. Radiology 1990; 174: 161163.
  • 121
    Guy F, Cognet F, Dranssart M, Cercueil JP, Conciatori L, Krausé D. Caroli's disease: magnetic resonance imaging features. Eur Radiol 2002; 12: 27302736.
  • 122
    Desmet VJ. What is congenital hepatic fibrosis? Histopathology 1992; 20: 465477.
  • 123
    Desmet VJ. Ductal plates in ductular reaction and implications. In preparation.
  • 124
    Callea F, Fevery J, Massi G, Lievens C, de Groote J, Desmet VJ. Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A “recruitment-secretory block” (“R-SB”) phenomenon. Liver 1984; 4: 325337.
  • 125
    Callea F, Brisigotti M, Faa G, Lucini L, Eriksson S. Identification of PiZ gene products in liver tissue by a monoclonal antibody specific for the Z mutant of alpha 1-antitrypsin. J Hepatol 1991; 12: 372376.
  • 126
    Callea F, de Vos R, Togni R, Tardanico R, Vanstapel MJ, Desmet VJ. Fibrinogen inclusions in liver cells: a new type of ground-glass hepatocyte. Immune light and electron microscopic characterization. Histopathology 1986; 10: 6573.
  • 127
    Callea F, Brisigotti M, Fabbretti G, Bonino F, Desmet VJ. Hepatic endoplasmic reticulum storage diseases. Liver 1992; 12: 357362.
  • 128
    Sciot R, Verhoeven G, Van Eyken P, Cailleau J, Desmet VJ. Transferrin receptor expression in rat liver: immunohistochemical and biochemical analysis of the effect of age and iron storage. HEPATOLOGY 1990; 11: 416427.
  • 129
    Sciot R, Paterson AC, Van den Oord JJ, Desmet VJ. Lack of hepatic transferrin receptor expression in hemochromatosis. HEPATOLOGY 1987; 7: 831837.
  • 130
    De Vos R, Sciot R, van Eyken P, Desmet VJ. Immunoelectron microscopic localization of hepatic transferrin receptors in human liver with and without iron overload. Virchows Arch B Cell Pathol Incl Mol Pathol 1988; 55: 1117.
  • 131
    Sciot R, van Eyken P, Facchetti F, Callea F, van der Steen K, van Dijck H, et al. Hepatocellular transferrin receptor expression in secondary siderosis. Liver 1989; 9: 5261.
  • 132
    Sciot R, Paterson AC, van Eyken P, Callea F, Kew MC, Desmet VJ. Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology 1988; 12: 5363.
  • 133
    Sciot R, Van Eyken P, Desmet VJ. Transferrin receptor expression in benign tumours and in hepatoblastoma of the liver. Histopathology 1990; 16: 5962.
  • 134
    Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495497.
  • 135
    Crocker J, ed. Molecular Biology in Histopathology. Chichester, UK: John Wiley and Sons; 1994.
  • 136
    Nuovo GJ. PCR In Situ Hybridization. Protocols and Applications. 2nd ed. New York: Raven Press; 1994.
  • 137
    Margulies DH. Monoclonal antibodies: producing magic bullets by somatic cell hybridization. J Immunol 2005; 174: 24512452.